Vulvo-Perineal Crohn’s Disease: A Challenging Diagnosis!
Main Article Content
Abstract
Crohn's disease (CD) is a chronic inflammatory bowel disease with polymorphous cutaneous manifestations. Vulvar localization is rare and may be either isolated, revealing the disease, or associated with digestive manifestations. Treatment is difficult and not well codified.
Based on 4 case reports of vulvo-perineal involvement, we present a reminder of the diagnostic and therapeutic challenges of this particular site.
In 2 out of 4 patients, vulvar involvement was incipient, with no gastrointestinal symptoms at the time of diagnosis. The vulva may present with many dermatological manifestations: knife-like ulcerations, oedema, labial hypertrophy, lymphangiectasia, abscesses and fistulae. The presence of non-caseating granulomas on histology may help to confirm the diagnosis.
Vulvar CD affects quality of life and requires long-term medical and surgical management with a multidisciplinary approach involving gastroenterologists, dermatologists, gynecologists and pathologists.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Capron, J. P., et al. Challenges in Diagnosing Vulvar Crohn's Disease: A Case Series." Journal of Crohn's and Colitis, vol. 14, no. 9, 2020, pp. 1234-1240. doi:10.1093/ecco-jcc/jjaa066.
II. Maximilien Barreta, Vincent de Paradesc, Maxime Battistella and al Crohn's disease of the vulva, Journal of Crohn's and Colitis.2014; 8: 563–570
III. Antonelli E, Bassotti G, Tramontana M, and al. Dermatological manifestations in inflammatory boweldiseases. J Clin Med. 2021;10(2):364.
IV. Aberumand B, Howard J, Howard J. Metastatic Crohn’s disease: anapproach to an uncommon but important cutaneous disorder. BiomedResInt.2017; 2017:8192150.
V. AbideJM. Metastatic Crohndisease: clearance with metronidazole. JAm Acad Dermatol. 2011;64(2):448-449.
VI. ColombelJF,Irving P, Rieder F, et al. Efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn’s disease. J CrohnsColitis. 2023;17(suppl 1):i620-i623.
VII. Loftus EVJr, PanésJ, LacerdaAP, etal. Upadacitinib induction and maintenance therapy for Crohn’s disease. NEnglJMed.2023;388(21):1966-1980.